Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. M. (Marco) de Bruyn

Publicaties

Biomarker and transcriptomics profiles of serum selenium concentrations in patients with heart failure are associated with immunoregulatory processes

ImmunoPET provides a novel way to visualize the CD103+ tissue-resident memory T cell to predict the response of immune checkpoint inhibitors.

Corrigendum to “NEAT1: Culprit lncRNA linking PIG[sbnd]C, MSLN, and CD80 in triple-negative breast cancer”

Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors

Development of [89Zr]Zr-hCD103.Fab01A and [68Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET

EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells

Prognostic benefit of TILs independent of clinicopathological and molecular factors

Tumour-infiltrating lymphocytes: from prognosis to treatment selection

Automated causal inference in application to randomized controlled clinical trials

cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers

Lees meer

Pers/media

UMCG ontvangt subsidie voor onderzoek naar immuuntherapie bij baarmoederkanker

Onstekingsremmer als mogelijk medicijn bij agressieve kankers

Bij agressieve kankers kunnen mogelijk ontstekingsremmers helpen

Onstekingsremmer als mogelijk medicijn bij agressieve kankers

Lees meer